import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "peptide-vendor-evaluation-checklist-researchers",
  title: "How to Evaluate a Peptide Vendor: A Researcher's Checklist",
  description:
    "A systematic checklist for evaluating research peptide suppliers — covering COA documentation standards, third-party testing verification, cold-chain protocols, synthesis methods, and red flags that indicate inadequate quality control.",
  category: "Vendor Guides",
  readMinutes: 8,
  publishedAt: "2026-06-04",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "The validity of any peptide research study depends on the quality and identity of the compounds used. Poor-quality peptide material introduces variability that can confound results, generate false negatives (impure compound that underperforms), false positives (contaminating biologics that produce artifact responses), or — in in vivo research — introduce animal welfare risks. Yet the research peptide supply market spans a wide quality range, from ISO 17025-accredited synthesis operations with fully documented quality systems to suppliers with minimal documentation and no third-party verification.",
    },
    {
      type: "paragraph",
      text: "This checklist provides a systematic framework for evaluating peptide vendors before procurement. It is organized by priority — address the most critical quality gatekeepers first.",
    },
    {
      type: "heading",
      text: "Tier 1: Non-Negotiable Documentation",
    },
    {
      type: "subheading",
      text: "1. Certificate of Analysis (COA) — Accessibility",
    },
    {
      type: "paragraph",
      text: "A COA should be publicly accessible on the vendor website for each specific lot number, or available for download without requiring account creation or contacting sales. Vendors who provide COAs 'upon request' or only after purchase are applying a significant friction barrier to quality verification — a practice inconsistent with research-grade supplier standards.",
    },
    {
      type: "list",
      items: [
        "✓ COA accessible on product page or searchable by lot number",
        "✓ COA includes: compound name, lot number, manufacturing date, expiry/retest date",
        "✓ COA matches specific product you are purchasing (not generic compound COA)",
        "✗ Red flag: COA 'available on request' — ask why it isn't public",
        "✗ Red flag: Single COA covers all batches with no lot-specific identification",
      ],
    },
    {
      type: "subheading",
      text: "2. HPLC Purity Data",
    },
    {
      type: "paragraph",
      text: "High-performance liquid chromatography (HPLC) purity analysis is the minimum acceptable analytical standard for research-grade peptide documentation. The COA should report a purity percentage (ideally ≥98% for research applications; ≥99% for sensitive protocols) along with the actual chromatogram or a reference to it.",
    },
    {
      type: "list",
      items: [
        "✓ HPLC purity ≥98% reported with actual percentage (not just 'high purity')",
        "✓ HPLC method specified (RP-HPLC, column type/gradient conditions noted)",
        "✓ Chromatogram available or verifiable peak area data reported",
        "✗ Red flag: Purity stated as a range ('97–99%') without a specific lot measurement",
        "✗ Red flag: No HPLC data — visual appearance or TLC only",
      ],
    },
    {
      type: "subheading",
      text: "3. Mass Spectrometry Identity Confirmation",
    },
    {
      type: "paragraph",
      text: "HPLC purity confirms that the compound is predominantly a single species — but it does not confirm that species is the correct compound. Mass spectrometry (MS) provides molecular weight verification, confirming that what is measured is the correct sequence. For modified peptides (e.g., CJC-1295 with DAC modification, PEGylated compounds), MS is essential to verify that the modification is present and correctly positioned.",
    },
    {
      type: "list",
      items: [
        "✓ Molecular weight or m/z data reported, matching the expected MW of the compound",
        "✓ ESI-MS or MALDI-TOF method specified",
        "✓ For modified peptides: confirmation that modification is correctly present",
        "✗ Red flag: COA has HPLC purity but no MS identity data",
        "✗ Red flag: MW reported as a range rather than a measured value",
      ],
    },
    {
      type: "heading",
      text: "Tier 2: Third-Party Verification",
    },
    {
      type: "subheading",
      text: "4. Independent Laboratory Testing",
    },
    {
      type: "paragraph",
      text: "Self-reported testing by the vendor's own QC laboratory is subject to obvious conflict of interest. Third-party testing — conducted by an independent analytical laboratory with no financial relationship to the vendor — provides a meaningful quality signal. The testing laboratory should ideally be ISO 17025 accredited.",
    },
    {
      type: "list",
      items: [
        "✓ Testing laboratory identified on COA (not just 'internal QC')",
        "✓ Laboratory name can be verified as a real independent entity",
        "✓ ISO 17025 accreditation of testing laboratory is a premium quality indicator",
        "✗ Red flag: COA identifies no testing laboratory",
        "✗ Red flag: Testing laboratory shares address or corporate affiliation with vendor",
      ],
    },
    {
      type: "subheading",
      text: "5. Endotoxin (LAL) Testing",
    },
    {
      type: "paragraph",
      text: "Limulus Amebocyte Lysate (LAL) testing detects bacterial lipopolysaccharide (LPS) endotoxin contamination. Endotoxin is a potent pro-inflammatory agent that produces artifact biological responses in cell-based and in vivo assays — including fever, inflammatory cytokine cascades, and immune cell activation — at concentrations in the low pg/mL range. For in vitro or in vivo research, endotoxin contamination is a significant confound.",
    },
    {
      type: "list",
      items: [
        "✓ LAL endotoxin test result reported in EU/mg or EU/mL",
        "✓ Result is below 1 EU/mg for general research use; ≤0.1 EU/mg for cell-based assays",
        "✓ Testing method specified (kinetic turbidimetric, chromogenic, gel-clot)",
        "✗ Red flag: No endotoxin data on COA",
        "✗ Red flag: Endotoxin result reported as 'pass/fail' without a quantitative threshold stated",
      ],
    },
    {
      type: "heading",
      text: "Tier 3: Logistics and Supply Chain",
    },
    {
      type: "subheading",
      text: "6. Cold-Chain Shipping Practices",
    },
    {
      type: "paragraph",
      text: "Many research peptides are temperature-sensitive in solution or as lyophilized powders, and require cold-chain handling during transit. Vendors who ship ambient without ice or dry ice for temperature-sensitive compounds introduce thermal degradation risk. Shipping practices should be documented and ideally disclosed in the product listing.",
    },
    {
      type: "list",
      items: [
        "✓ Temperature-sensitive compounds shipped on ice packs or dry ice",
        "✓ Packaging is insulated; transit time is minimized for perishable products",
        "✓ Vendor discloses shipping conditions and transit temperature exposure data where available",
        "✗ Red flag: No cold-chain documentation for compounds with known temperature sensitivity",
        "✗ Red flag: Shipping containers are standard uninsulated parcels for lyophilized peptides in summer/warm climates",
      ],
    },
    {
      type: "subheading",
      text: "7. Synthesis Origin and Manufacturing Transparency",
    },
    {
      type: "paragraph",
      text: "Peptide synthesis capacity varies significantly. Some vendors operate their own GMP or research-grade synthesis facilities; others are essentially resellers of contract-manufactured product from a small number of large-scale synthesis providers, often based in China. Neither model is inherently inferior — large contract synthesis facilities can produce exceptional research-grade product — but transparency about the supply chain matters for traceability.",
    },
    {
      type: "list",
      items: [
        "✓ Vendor is transparent about synthesis origin (in-house vs. contract manufacturer)",
        "✓ Contract manufacturers have verifiable quality credentials",
        "✗ Red flag: Vendor claims in-house synthesis but has no facility details, staff, or history",
        "✗ Red flag: Same COA format and lot number structure as multiple other vendors — suggests undifferentiated commodity resale",
      ],
    },
    {
      type: "heading",
      text: "Tier 4: Business Credibility Indicators",
    },
    {
      type: "paragraph",
      text: "Beyond analytical documentation, several operational signals indicate a vendor with durable quality standards:",
    },
    {
      type: "list",
      items: [
        "Research community presence: vendor is referenced in academic publications or cited by known researchers (even informally in forums where researchers discuss sourcing)",
        "Responsive technical support: ability to answer compound-specific questions about reconstitution, stability, or analytical methods — not just sales-team generic responses",
        "Consistent lot-to-lot COA quality: COAs from different batches maintain the same documentation standards and independent lab testing",
        "Clear regulatory compliance posture: vendor documentation acknowledges research-use-only status and complies with applicable domestic regulations",
        "Return/replacement policy: reputable vendors stand behind their product quality; unwillingness to address documented quality failures is a significant negative signal",
      ],
    },
    {
      type: "heading",
      text: "Summary Checklist",
    },
    {
      type: "table",
      headers: ["Category", "Requirement", "Priority"],
      rows: [
        ["COA Access", "Publicly available, lot-specific", "Critical"],
        ["HPLC Purity", "≥98%, chromatogram verifiable", "Critical"],
        ["MS Identity", "MW confirmed vs. expected sequence", "Critical"],
        ["3rd Party Testing", "Independent lab identified", "High"],
        ["Endotoxin (LAL)", "Quantitative result, ≤1 EU/mg", "High"],
        ["Cold-Chain Shipping", "Insulated + ice for sensitive compounds", "High"],
        ["Supply Chain Transparency", "Synthesis origin disclosed", "Moderate"],
        ["Technical Support", "Compound-specific expertise accessible", "Moderate"],
        ["Reputation", "Research community references", "Moderate"],
      ],
    },
    {
      type: "paragraph",
      text: "No single vendor will achieve perfect marks across every category. The goal is to identify vendors with strong Tier 1 and Tier 2 documentation — the analytical fundamentals that directly affect experimental validity — and treat Tier 3–4 indicators as differentiators when choosing among verified-quality options.",
    },
    {
      type: "disclaimer",
      text: "For research purposes only. Not intended for human or veterinary therapeutic use.",
    },
  ],
};
